Phase 2 Study of Novel Partial Tumor Irradiation for Sparing Peri-Tumoral Immune Microenvironment.

被引：0
|
作者：
Tubin, S. [1 ]
Khan, M. K. [2 ]
Salerno, G. [3 ]
Mourad, W. F. [4 ]
Yan, W. [5 ]
Jeremic, B. [6 ,7 ,8 ]
机构：
[1] Landeskrankenhaus Klagenfurt, Strahlentherapie & Radioonkol, Klagenfurt, Austria
[2] Emory Univ, Sch Med, Winship Canc Ctr, Dept Radiat Oncol, Atlanta, GA 30322 USA
[3] Univ Roma La Sapienza, Osped St Andrea, Dept Neurosci Mental Hlth & Sensory Organs, Dept Clin & Mol Med, Rome, RM, Italy
[4] Univ Kentucky, Dept Radiat Med, Markey Canc Ctr, Lexington, KY USA
[5] Thomas Jefferson Univ Philadelphia, Dept Radiat Oncol, Philadelphia, PA USA
[6] Res Inst Clin Med, Tbilisi, Georgia
[7] BioIRC R&D Ctr Biomed Res, Kragujevac, Serbia
[8] Dept Radiat Oncol, Tbilisi, Georgia
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PH-0282
引用
收藏
页码：S142 / S143
页数：2
相关论文
共 50 条
  • [11] A phase 0 exploratory study to assess the pharmacodynamic effects of single intratumoral dose of a novel bispecific targeting/immune-activating agent on the melanoma tumor microenvironment.
    Fecher, L. A.
    McGrath, Y.
    Williams, D. D.
    Hassan, N. J.
    Kalos, M.
    Schuchter, L. M.
    Amaravadi, R. K.
    Chew, A.
    Veloso, E. A.
    Czerniecki, B. J.
    Karakousis, G.
    Linette, G. P.
    Jakobsen, B. K.
    June, C. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [12] CT perfusion imaging can detect residual lung tumor early after radiofrequency ablation: a preliminary animal study on both tumoral and peri-tumoral region assessment
    Cheng, Zenghui
    Wang, Yixue
    Yuan, Min
    Liang, Jianxiao
    Feng, Yanling
    Shi, Yuxin
    Zhang, Zhiyong
    Shan, Fei
    JOURNAL OF THORACIC DISEASE, 2022, 14 (01) : 64 - +
  • [13] Novel TNFR2 antibodies to overcome T cell exhaustion and suppressive tumor microenvironment.
    Sum, Chi Shing
    Danton, Makenzie
    Hu, Qihui
    Pritsker, Alla
    Lin, Ray
    Yu, Raymond
    Chen, Kevin
    Tang, Fangqiang
    Pohl, Thomas
    Wallner, Samantha
    Hassan, Ahmed
    Lu, Huarui
    Huang, Haichun
    Pei, James
    Liu, Zhong
    Li, Han
    Lei, Ming
    CANCER RESEARCH, 2021, 81 (13)
  • [14] Lineage specifiers SOX2 and NKX2-1 inversely regulate lung tumor immune microenvironment.
    Mollaoglu, Gurkan
    Jones, Alex
    Mukhopadhyay, Anandaroop
    Gertz, Jason
    Jones, Kevin
    Snyder, Eric
    Oliver, Trudy G.
    CANCER RESEARCH, 2018, 78 (10) : 25 - 25
  • [15] Peri-tumoral expression of interleukin-12 is effective against implanted tumors in the liver of syngeneic mice, but achieves only partial protection against distant tumor rechallenge
    Gonzalez-Aparicio, Manuela
    Alzuguren, Pilar
    Mauleon, Itsaso
    Crettaz, Julien
    Gonzalez-Aseguinolaza, Gloria
    Prieto, Jesus
    Hernandez-Alcoceba, Ruben
    HUMAN GENE THERAPY, 2008, 19 (10) : 1107 - 1108
  • [16] A novel technique of lymphoscintigraphy and sentinel node detection in endometrial cancer by the hysteroscopic peri-tumoral injection of 99mTc labelled albumin nanocolloid:: Results of a pilot study
    Maccauro, M
    Solima, E
    Villano, C
    Aliberti, G
    Castellani, M
    Savelli, G
    Raspagliesi, F
    Bombardieri, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S454 - S454
  • [17] CT-0508, a novel CAR macrophage product directed against HER2, promotes a proinflammatory tumor microenvironment.
    Gabrusiewicz, Konrad
    Anderson, Nicholas
    Lu, Xueqing
    Shan, Xinhe
    Shestova, Olga
    Petty, Nicholas
    Shen, Feng
    Schmierer, Maggie
    Best, Andrew
    Zeeman, Martha
    Ohtani, Yumi
    Cummins, Katherine
    Gill, Saar
    Klichinsky, Michael
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 117 - 118
  • [18] Novel time-synchronized immune-guided partial tumor irradiation: Proof of principle trial
    Tubin, S.
    Ashdown, M. L.
    Ahmed, M. M.
    Guha, C.
    Salerno, G.
    Celedin, B.
    Trummer, B.
    Demschar, S.
    Raunik, W.
    RADIOTHERAPY AND ONCOLOGY, 2024, 199
  • [19] Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment
    Liu, Yang
    Guo, Qiang
    Yang, Heng
    Zhang, Xiao-Wen
    Feng, Na
    Wang, Jing-Kang
    Liu, Ting-Ting
    Zeng, Ke-Wu
    Tu, Peng-Fei
    ACS CENTRAL SCIENCE, 2022, 8 (08) : 1102 - 1115
  • [20] A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study
    Huang, Yizhou
    Chen, Lizhi
    Tang, Ziyi
    Min, Yu
    Yu, Wanli
    Yang, Gangyi
    Zhang, Lili
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
12345